XRAY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XRAY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Dentsply Sirona's Capital Expenditure for the three months ended in Sep. 2024 was $-43.00 Mil. Its Operating Income for the three months ended in Sep. 2024 was $64.00 Mil.
Hence, Dentsply Sirona's Capex-to-Operating-Income for the three months ended in Sep. 2024 was 0.67.
The historical data trend for Dentsply Sirona's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Capex-to-Operating-Income | Get a 7-Day Free Trial | 0.28 | 0.38 | 0.23 | 0.42 | 0.53 |
Dentsply Sirona Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Capex-to-Operating-Income | Get a 7-Day Free Trial | 0.49 | 0.59 | 0.72 | 0.75 | 0.67 |
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's Capex-to-Operating-Income falls into.
Dentsply Sirona's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as
Capex-to-Operating-Income | = | - Capital Expenditure | / | Operating Income |
= | - (-149) | / | 282 | |
= | 0.53 |
Dentsply Sirona's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as
Capex-to-Operating-Income | = | - Capital Expenditure | / | Operating Income |
= | - (-43) | / | 64 | |
= | 0.67 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona (NAS:XRAY) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Thank you for viewing the detailed overview of Dentsply Sirona's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Gregory T Lucier | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Simon D Campion | director, officer: President, CEO & Member of BOD | DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Glenn Coleman | officer: Executive VP & CFO | C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Andrea L. Frohning | officer: SVP, CHRO | C/O DENTSLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Jonathan Jay Mazelsky | director | ONE IDEXX DRIVE, WESTBROOK ME 04092 |
Eric Brandt | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Staehler Cord Friedrich | officer: SVP, Chief Technology Officer | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Richard C Rosenzweig | officer: SVP, Corp Dev, GC & Secretary | C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Robert Anthony Johnson | officer: SVP, Chief Supply Chain Office | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Richard M Wagner | officer: VP, Chief Accounting Officer | 221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991 |
Barbara W. Bodem | officer: Interim CFO | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Willem T Appelo | officer: SVP Chief Supply Chain Officer | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Andreas G Frank | officer: Executive VP, Product Group | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
John P Groetelaars | director | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Cheree H Johnson | officer: SVP,Chief Legal Ofcr, GC &Sec | C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
From GuruFocus
By Business Wire • 12-03-2024
By Marketwired • 12-04-2024
By PRNewswire • 12-05-2024
By Business Wire • 11-27-2024
By Marketwired • 11-28-2024
By Marketwired • 12-02-2024
By Marketwired • 11-27-2024
By Marketwired • 12-02-2024
By Business Wire • 12-02-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.